You are here: Industry Insights > vaccine

News List

Alzamend Neuro Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-allotment Option for Gross Proceeds of $14.4 Million firstwordpharma
June 18, 2021
Alzamend Neuro, today announced the closing of its initial public offering of 2,500,000 shares of its common stock and full exercise of the underwriter's over-allotment option to purchase 375,000 additional shares of common stock at a price to the public
Ahead of Tokyo Olympics, Japan Eases COVID-19 Restrictions drugs
June 18, 2021
A coronavirus state of emergency in Tokyo and six other areas will be downgraded when it expires on Sunday as new daily cases continue to decline, the Japanese government said Thursday.
CureVac's COVID-19 Vaccine Only 47 Percent Effective drugs
June 18, 2021
CureVac's COVID-19 vaccine was only 47 percent effective in a clinical trial, according to preliminary results released Wednesday that suggest the vaccine may not help fill the worldwide need for vaccines.
Drop in Havana COVID-19 cases boosts hopes Cuban vaccines working firstwordpharma
June 18, 2021
Official data from Cuba indicate that COVID-19 infections have halved in Havana since authorities started administering the country's experimental vaccines in the capital a month ago, raising hopes about their efficacy even as cases increase nationwide
New York Lifts Pandemic Restrictions drugs
June 17, 2021
New York state has reached a milestone of having at least one COVID-19 vaccine dose in 70 percent of its residents and joined California in lifting many pandemic restrictions on Tuesday.
CureVac blames variants for COVID-19 vaccine fail in pivotal trial firstwordpharma
June 17, 2021
CureVac's stock was cut in half on Wednesday after the company reported that its vaccine candidate CVnCoV was only 47% effective at preventing COVID-19 disease of any severity in a second interim analysis, falling short of pre-specified statistical.
China’s First mRNA Covid-19 Vaccine Preps to Enter Final Stage Trials, Abogen CEO Says firstwordpharma
June 17, 2021
Suzhou Abogen Biosciences’ mRNA COVID-19 vaccine is expected to start Phase III tests in overseas countries later this month, said CEO Ying Bo, Yicai Global reported.
Brazil to buy single-shot Chinese COVID-19 vaccine PharmaSources
June 17, 2021
According to a negotiation document, Brazil plans to purchase 60 million doses of the single-shot COVID-19 vaccine developed by China's CanSino Biologics for delivery in the third and fourth quarters of this year, as reported by NASDAQ.
eTrueNorth Offers Five Tips for Travel-related COVID Testing prnewswire
June 17, 2021
eTrueNorth is one of the largest providers of COVID-19 tests to Americans.
Third Dose of COVID Vaccine Boosts Protection in Transplant Recipients drugs
June 16, 2021
Researchers say an extra dose of two-dose COVID-19 vaccines may improve immune system protection for organ transplant patients, a group that's so far responded poorly to two-dose vaccines.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page